130 results match your criteria: "Austrian National Public Health Institute (Gesundheit Österreich GmbH[Affiliation]"

Perinatal and infant mental health care in Austria : Mapping of existing prevention, screening, and care services.

Neuropsychiatr

December 2024

Department for Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, Medical University Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.

Purpose: Perinatal mental illness (PMI) is one of the major health problems during pregnancy and one year after birth (the perinatal period), with robust evidence of its potentially detrimental effects on the parent's and child's health. Many countries have prioritised perinatal and infant mental health care (PIMHC). In Austria, it is currently unknown how many services are available in which region.

View Article and Find Full Text PDF
Article Synopsis
  • - The study explores the implementation of injectable opioid agonist treatment (iOAT) with diacetylmorphine and hydromorphone, aiming to identify key barriers and facilitators impacting its success.
  • - A systematic review of 44 articles reveals barriers such as public acceptance issues, legal challenges, negative media portrayals, and high costs, alongside regulatory constraints faced by patients and providers.
  • - Facilitators for effective iOAT include integrating treatments into broader drug policies, publishing supportive data for public discussion, and ensuring ethical compliance through dedicated committees.
View Article and Find Full Text PDF

Improving antibiotic prescribing - Recommendations for funding and pricing policies to enhance use of point-of-care tests.

Health Policy Open

December 2024

WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (GÖG/Austrian National Public Health Institute), Stubenring 6, 1010 Vienna, Austria.

Introduction: Diagnostics can contribute to the improved quality of antibiotic prescribing. However, there is potential to enhance the use of point-of-care tests (POCTs) in general practice. This paper presents fit-for-purpose policy recommendations related to funding and pricing for POCTs applied for community-acquired acute respiratory tract infections (CA-ARTIs).

View Article and Find Full Text PDF

Importance: Randomized clinical trials (RCTs) are widely regarded as the methodological benchmark for assessing clinical efficacy and safety of health interventions. There is growing interest in using nonrandomized studies to assess efficacy and safety of new drugs.

Objective: To determine how treatment effects for the same drug compare when evaluated in nonrandomized vs randomized studies.

View Article and Find Full Text PDF

Innovation in cancer therapy has increased childhood cancer survival rates. However, survivors are still at risk of developing late effects. In the digital transformation of the health sector, the Survivorship Passport (SurPass) can support long-term follow-up care plans.

View Article and Find Full Text PDF

Background: Before the COVID-19 pandemic, a need for a uniform approach to health information (HI) knowledge in population health analysis across Europe was evident. The Population Health Information Research Infrastructure (PHIRI) emerged as a proactive initiative to strengthen European HI capacities. This article describes the achievements of PHIRI, highlighting its capacity-building activities and their contribution towards a sustainable strategy for the implementation of the European Health Data Space (EHDS).

View Article and Find Full Text PDF

Background: To overcome knowledge gaps and optimize long-term follow-up (LTFU) care for childhood cancer survivors, the concept of the Survivorship Passport (SurPass) has been invented. Within the European PanCareSurPass project, the semiautomated and interoperable SurPass (version 2.0) will be optimized, implemented, and evaluated at 6 LTFU care centers representing 6 European countries and 3 distinct health system scenarios: (1) national electronic health information systems (EHISs) in Austria and Lithuania, (2) regional or local EHISs in Italy and Spain, and (3) cancer registries or hospital-based EHISs in Belgium and Germany.

View Article and Find Full Text PDF

Real-world data (RWD) can provide intel (real-world evidence, RWE) for research and development, as well as policy and regulatory decision-making along the full spectrum of health care. Despite calls from global regulators for international collaborations to integrate RWE into regulatory decision-making and to bridge knowledge gaps, some challenges remain. In this work, we performed an evaluation of Austrian RWD sources using a multilateral query approach, crosschecked against previously published RWD criteria and conducted direct interviews with representative RWD source samples.

View Article and Find Full Text PDF

Background: Errors of omissions affect the quality of nursing care in hospitals. The Missed Nursing Care Model explains that the reasons for missed care are linked with 1) demand for patient care, 2) labor resource allocation, 3) material resource allocation, and 4) relationship and communication factors. Scientific evidence points to a lack of adequate nursing staffing as the most important factor triggering missed care.

View Article and Find Full Text PDF

Tackling medicine shortages during and after the COVID-19 pandemic: Compilation of governmental policy measures and developments in 38 countries.

Health Policy

May 2024

WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (GÖG / Austrian National Public Health Institute), Stubenring 6, 1010 Vienna, Austria; Department of Health Care Management, Technische Universität Berlin, Straße des 17. Juni 135, 10623 Berlin, Germany. Electronic address:

In response to increasing shortages of medicines, governments have implemented legislative and non-legislative policy measures. This study aimed to map these policies across high-income countries in Europe and beyond as of 2023 and to analyse developments in governmental approaches since the beginning of the pandemic. Information was collated from 38 countries (33 European countries, Australia, Brazil, Canada, Israel and Saudi Arabia) based on a survey conducted with public authorities involved in the Pharmaceutical Pricing and Reimbursement Information (PPRI) network in 2023.

View Article and Find Full Text PDF

Objectives: In the Global North, the number of older people living alone who have little or no support from family members is increasing. However, little is known about older people living alone who have basic needs for support but do not have kin living nearby or a sustainable relationship to a relative they can rely on. Thus, this paper focuses on the role of nonkin carers and their contribution to the support arrangements of older people living alone.

View Article and Find Full Text PDF

Background And Aims: OAT is a well developed and successful treatment strategy for opioid dependent patients in Europe. It has significantly contributed to the fight against the HIV and HCV pandemics, leading to an increased life expectancy in this population. Building on the OAT experiences in Austria, Germany, and Switzerland and their models of care, the objective of this study is to analyse experiences and changes in patient structures to identify necessary adaptations for the system of care.

View Article and Find Full Text PDF
Article Synopsis
  • * The study examined barriers and facilitators to adopting these rapid diagnostics in five European countries, focusing on health technology assessment (HTA), pricing, and funding policies.
  • * Key barriers include lack of evidence for HTA processes and absence of price regulation, while potential facilitators are reimbursement coverage and better compensation for doctors using these tests, indicating room for improvement in policies to encourage their use.
View Article and Find Full Text PDF

Background: People who inject drugs (PWID) in Europe are at an increased risk of HIV/AIDS, chronic viral hepatitis B (HBV) and C (HCV), and tuberculosis (TB). We aimed to complement the evidence base on interventions optimising their care cascade with evidence from models of good practice (MoGPs) implemented in the EU/EEA and countries from the Eastern European region.

Methods: A model of good practice (MoGP) was defined as (a package of) interventions with proven effectiveness in certain settings that are likely to be replicable and sustainable in other settings or countries.

View Article and Find Full Text PDF

Impacts of public health and social measures on COVID-19 in Europe: a review and modified Delphi technique.

Front Public Health

September 2023

CHRC, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.

Introduction: The emergence of the COVID-19 pandemic in early 2020 led countries to implement a set of public health and social measures (PHSMs) attempting to contain the spread of the SARS-CoV-2 virus. This study aims to review the existing literature regarding key results of the PHSMs that were implemented, and to identify the PHSMs considered to have most impacted the epidemiological curve of COVID-19 over the last years during different stages of the pandemic.

Methods: The PHSM under study were selected from the Oxford COVID-19 Government Response Tracker (OxCGRT), supplemented by topics presented during the Rapid Exchange Forum (REF) meetings in the scope of the Population Health Information Research Infrastructure (PHIRI) project (H2020).

View Article and Find Full Text PDF

Background: The recent World Health Organization (WHO) blueprint for dementia research and Lancet Commission on ending stigma and discrimination in mental health has identified a gap around dementia-related measures of stigma and discrimination that can be used in different cultural, language and regional contexts.

Aims: We aimed to characterise experiences of discrimination, and report initial psychometric properties of a new tool to capture these experiences, among a global sample of people living with dementia.

Method: We analysed data from 704 people living with dementia who took part in a global survey from 33 different countries and territories.

View Article and Find Full Text PDF

Introduction: Pharmaceutical systems are frequently characterized by fragmentation, and competences for outpatient and inpatient sectors sit with different authorities, payers, and purchasers. This fragmentation of responsibilities can incentivize shifting expensive therapies and thus patients from one sector to the other.

Areas Covered: Reimbursement and procurement policies in Europe addressing unwanted consequences of this fragmentation were identified through literature reviews and surveys with policy-makers.

View Article and Find Full Text PDF
Article Synopsis
  • More people with dementia live in low- and middle-income countries (LMICs), but most care recommendations come from high-income countries, leading to a research gap.
  • A systematic analysis of 340 randomized controlled trials (RCTs) related to dementia interventions in LMICs was conducted, focusing on studies published from 2008 to 2018, with the majority of studies stemming from China.
  • Most interventions were in the form of Traditional Chinese Medicine, Western pharmaceuticals, and supplements, but a significant number of studies had a high risk of bias, indicating that more diverse and rigorous research is necessary in underrepresented LMICs.
View Article and Find Full Text PDF

The European health data space: Too big to succeed?

Health Policy

September 2023

Finnish Biobank Cooperation (FINBB), Turku, 20540, Finland; Faculty of Law, University of Turku, 20014 Turun yliopisto, Finland.

In May 2022, the European Commission issued the Proposal for a Regulation on the European Health Data Space (EHDS), with the aims of granting citizens increased access to and control of their (electronic) health data across the EU, and facilitating health data re-use for research, innovation, and policymaking. As the first in a series of European domain-specific "data spaces", the EHDS is a high-stakes development that will transform health data governance in the EU region. As an international consortium of experts from health policy, law, ethics and the social sciences, we are concerned that the EHDS Proposal will detract from, rather than lead to the achievement of, its stated aims.

View Article and Find Full Text PDF

Background: Recent reforms in Austria have focused on establishing team-based care within multiprofessional primary care units, to enhance amongst others, the work attractiveness of general practice. Nearly 75% of qualified general practitioners are not working as contracted physicians with the social health insurance. This study aims to explore the facilitators of and barriers to non-contracted general practitioners to work in a primary care unit.

View Article and Find Full Text PDF

The Austrian government introduced in spring 2020 COVID-19 containment policies that had various impacts on older people living alone (OPLA) and their care arrangements. Seven qualitative telephone interviews with OPLA were conducted to explore how they were affected by these policies. The findings show that the management of everyday life and support was challenging for OPLA even though they did not perceive the pandemic as a threat.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how different Portuguese NHS hospitals adopt biosimilars compared to originator biologic drugs, focusing on factors influencing this uptake from 2015 to 2021.
  • Analysis shows that academic hospitals adopted certain biosimilars faster, while higher overall biologic usage corresponded with lower biosimilar uptake.
  • Improving awareness and training on biosimilar prescribing could lead to significant cost savings, potentially totaling 13.9 million euros annually if all hospitals matched the highest uptake rates.
View Article and Find Full Text PDF

Background And Purpose: Studies on mechanical thrombectomy (MT) in acute ischemic stroke (AIS) patients with preexisting disability are limited. We aimed to compare the outcomes of MT versus best medical treatment (BMT) in these patients.

Methods: In the nationwide Austrian registry and Swiss monocentric registry, we identified 462 AIS patients with pre-stroke disability (modified Rankin Scale [mRS] score ≥3) and acute large vessel occlusion.

View Article and Find Full Text PDF